Related Experiment Video
Updated: Dec 18, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Hot topics in coagulation testing: Important considerations for testing children for bleeding/thrombotic disorders.
Marzia Rahman1, Carly George1, Paul Monagle1
1Department of Clinical Haematology, Laboratory Services, Royal Children's Hospital, Parkville, Vic., Australia.
Coagulation testing presents challenges in standardization and interpretation, particularly for pediatric patients. Addressing controversies in reference ranges, anticoagulation monitoring, and thrombin generation tests is crucial for improving patient care across all ages.
Area of Science:
- Clinical Pathology
- Hematology
- Diagnostic Testing
Background:
- Accurate coagulation testing is vital for patient care but faces interpretation challenges.
- Standardization, patient population applicability, and result interpretation are key areas of controversy.
Purpose of the Study:
- To identify and discuss prominent controversies in coagulation testing.
- To highlight specific challenges in age-appropriate reference ranges, anticoagulation monitoring, and thrombin generation tests, using pediatric examples.
Main Methods:
- Review and discussion of existing literature on coagulation testing controversies.
- Focus on three specific areas: age-specific reference intervals, therapeutic anticoagulation monitoring (APTT and anti-Xa assays), and thrombin generation assays.
- Utilizing pediatric cases to illustrate broader implications.
Main Results:
- Limitations exist in age-partitioned reference intervals due to developmental hemostasis.
- Difficulties in establishing normative data and managing pre-analytical variables impact test reliability.
- Challenges persist in interpreting heparin monitoring assays and thrombin generation tests due to assay limitations and biological variability.
Conclusions:
- Controversies in coagulation testing, exemplified by pediatric cases, affect patients of all ages.
- There is a pressing need for further research to address standardization and interpretation issues in coagulation diagnostics.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

